Save the Date! Location: Warsaw Date: Friday, September 20, 2024 The primary objective of the Investigator Brochure (IB) in a Phase 1 trial is to serve the responsible investigator for… Read More
26.04.2024 – ToxAIcology – AI as the New Frontier in Risk Assessment
Format: Webinar Date: Friday, April 26, 2024 from 4:00 PM to 5:30 PM Speaker: Thomas Hartung, Professor at Johns Hopkins Bloomberg School of Public Health The synergy of data generation and… Read More
15.12.2023: EUFEMED Scientific Christmas lecture: The (early) clinical development of new analgesics: the point of view of a pain clinician (online)
Scientific Christmas Lecture Webinar on 15 December 2023 at 16:00-17:30 CET Organiser: Jan De Hoon SAVE THE DATE!
15.09.2023: Patient/Participant engagement in exploratory clinical development (online)
Patient/Participant engagement in exploratory clinical development Webinar on 15 September 2023 at 16:00-17:30 CET Organiser: Ingrid Klingmann Register Here
25-26.05.2023 – 4th EUFEMED Conference: Mastering the New Time Pressure on Human Pharmacology
EUFEMED is delighted to announce our 4th Conference on 25th – 26th May 2023 Pre-workshop on May 24, 2023 Langenbeck-Virchow Haus Berlin Germany The Conference is entitled Mastering the New… Read More
16.12.2022: The (early) clinical development of new analgesics: the point of view of a pain clinician (online)
EUFEMED Innovation Club Workshop Webinar on 16 December 2022 at 16:00-17:30 CET In the first part of this webinar an overview will be provided of the wide “landscape” of pain… Read More
18.11.2022: Reporting obligations under the clinical trial regulation: SUSARs, serious breaches, summary of trial results and lay summaries (online)
EUFEMED Innovation Club Workshop Summary The new clinical trials regulation (CTR) is replacing the old clinical trials directive (CTD), and the text of the CTR now has to be implemented… Read More
16.10.2022: Submitting an application for a CTA and what do sponsors from outside the EU need to consider (online)
EUFEMED Innovation Club Workshop Summary Under the clinical trial regulation (CTR), authorisation of the clinical trial application (CTA) has to occur through a new process: a single dossier has to… Read More
13.05.2022: An overview of changing aspects for national Phase I trials under the EU Clinical Trial Regulation (online)
EUFEMED Innovation Club Workshop Summary The new clinical trial regulation (CTR) is replacing the old directive, where the text has to now be implemented in a national legislation. This will… Read More
28-30.05.2021: EUFEMED Virtual Annual Conference 2021
EUFEMED is delighted to announce that our Annual Conference 2021 will be going ahead virtually in a new and exciting format. The third EUFEMED CONFERENCE will be held on 28-30… Read More